These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9470884)

  • 1. Three year continuous abstinence in a smoking cessation study using the nicotine transdermal patch.
    Richmond RL; Kehoe L; de Almeida Neto AC
    Heart; 1997 Dec; 78(6):617-8. PubMed ID: 9470884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transdermal nicotine patch: results of a randomised placebo-controlled trial.
    Richmond RL; Harris K; de Almeida Neto A
    Med J Aust; 1994 Jul; 161(2):130-5. PubMed ID: 8028537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a 24-hour transdermal nicotine patch in conjunction with a cognitive behavioural programme: one year outcome.
    Richmond RL; Kehoe L; de Almeida Neto AC
    Addiction; 1997 Jan; 92(1):27-31. PubMed ID: 9060195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
    Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG
    JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia.
    Chou KR; Chen R; Lee JF; Ku CH; Lu RB
    Int J Nurs Stud; 2004 Mar; 41(3):321-30. PubMed ID: 14967189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varying nicotine patch dose and type of smoking cessation counseling.
    Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB
    JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
    Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
    Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers.
    Perkins KA; Lerman C; Keenan J; Fonte C; Coddington S
    Nicotine Tob Res; 2004 Jun; 6(3):501-7. PubMed ID: 15203784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia.
    George TP; Ziedonis DM; Feingold A; Pepper WT; Satterburg CA; Winkel J; Rounsaville BJ; Kosten TR
    Am J Psychiatry; 2000 Nov; 157(11):1835-42. PubMed ID: 11058482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial.
    Kornitzer M; Boutsen M; Dramaix M; Thijs J; Gustavsson G
    Prev Med; 1995 Jan; 24(1):41-7. PubMed ID: 7740014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Smoking cessation program using nicotine patch among physicians and pharmacists of Catalonia: results after 3-12 months].
    Pardell H; Salto E; Ciruela J; Tresserras R; Gascon P; Salleras L
    An Med Interna; 1996 Jan; 13(1):16-20. PubMed ID: 8679817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group.
    JAMA; 1991 Dec; 266(22):3133-8. PubMed ID: 1956099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of studies investigating one-year effectiveness of transdermal nicotine patches for smoking cessation.
    Myung SK; Yoo KY; Oh SW; Park SH; Seo HG; Hwang SS; Park SK
    Am J Health Syst Pharm; 2007 Dec; 64(23):2471-6. PubMed ID: 18029953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
    Yudkin PL; Jones L; Lancaster T; Fowler GH
    Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.
    Dale LC; Hurt RD; Offord KP; Lawson GM; Croghan IT; Schroeder DR
    JAMA; 1995 Nov; 274(17):1353-8. PubMed ID: 7563559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone and nicotine patch smoking cessation: a preliminary study.
    Krishnan-Sarin S; Meandzija B; O'Malley S
    Nicotine Tob Res; 2003 Dec; 5(6):851-7. PubMed ID: 14750508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
    Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
    Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation.
    Perng RP; Hsieh WC; Chen YM; Lu CC; Chiang SJ
    J Formos Med Assoc; 1998 Aug; 97(8):547-51. PubMed ID: 9747065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A double-blind trial of nicotine patches in smoking cessation].
    Tønnesen P; Nørregaard J; Simonsen K; Säwe U
    Ugeskr Laeger; 1992 Jan; 154(5):251-4. PubMed ID: 1736456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended nortriptyline and psychological treatment for cigarette smoking.
    Hall SM; Humfleet GL; Reus VI; Muñoz RF; Cullen J
    Am J Psychiatry; 2004 Nov; 161(11):2100-7. PubMed ID: 15514412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.